Skip to main content
BRAIN Biotech AG logo

BRAIN Biotech AG — Investor Relations & Filings

Ticker · BNN ISIN · DE0005203947 LEI · 391200JKPVHLD6JLZ107 F Professional, scientific and technical activities
Open in API
Filings indexed 368 across all filing types
Latest filing 2018-08-30 Governance Information
Country DE Germany
Listing F BNN

About BRAIN Biotech AG

https://www.brain-biotech.com/

BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.

Recent filings

Filing Released Lang Actions
B.R.A.I.N. Biotechnology Research And Information Network AG: Natural-based Sweeteners - DOLCE core team announces membership changes in programme for natural-based sweeteners
Governance Information Classification · 99% confidence The document is a news release dated August 30, 2018, originating from B.R.A.I.N. Biotechnology Research And Information Network AG, disseminated via DGAP-News. The content announces changes in the membership of the 'DOLCE core team' related to a programme for natural-based sweeteners. This type of announcement, which communicates operational updates, partnership changes, or general corporate news that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV), is best classified as a general Regulatory Filing or News Release. Since 'RNS' (Regulatory Filings) is defined as the fallback for miscellaneous filings that do not neatly fit elsewhere, and this is clearly a corporate news announcement, RNS is the most appropriate code. The document length is substantial (9051 chars), so it is not a simple RPA.
2018-08-30 English
B.R.A.I.N. Biotechnology Research And Information Network AG: Biological Wound Care - BRAIN AG announces the creation of SolasCure Ltd. to continue development of Aurase(R)
Regulatory Filings Classification · 100% confidence The document is a press release dated August 22, 2018, disseminated via DGAP, announcing a strategic corporate decision: BRAIN AG is creating a new entity, SolasCure Ltd., to continue the development of its Aurase(R) technology, including a Series A financing round. This announcement details a significant corporate restructuring and strategic partnership/spin-off, which involves licensing IP and providing technology. This type of announcement, detailing strategic corporate decisions, management changes related to new ventures, or significant business restructuring that isn't purely financial results (ER/IR) or a formal regulatory filing (10-K/AR), fits best under a category related to corporate actions or strategic updates. Since it is not a change in Board/Management (MANG), a financing update (CAP, as it's about spinning off a development program), or a merger (TAR), it is best classified as a general corporate announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate news release disseminated via a service like DGAP that doesn't fit a more specific category like ER, IR, or CAP, although it describes a strategic business development.
2018-08-22 English
B.R.A.I.N. Biotechnology Research And Information Network AG: Frank Goebel, CFO of BRAIN AG, has asked the Supervisory Board for early termination of his Management Board contract for personal reasons
Board/Management Information Classification · 100% confidence The document is a news release announcing a change in senior management: the CFO, Frank Goebel, has requested early termination of his contract for personal reasons. This directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The presence of DGAP-News headers and the focus on personnel change confirm this classification.
2018-08-07 English
B.R.A.I.N. Biotechnology Research And Information Network AG: Green Mining - BRAIN AG and CyPlus GmbH develop disruptive technologies for biological processing of precious metal ores
Environmental & Social Information Classification · 99% confidence The document is a press release dated June 20, 2018, disseminated via DGAP, which is a service for financial news and regulatory announcements. The content describes a collaboration between BRAIN AG and CyPlus GmbH on developing technologies for precious metal ore processing, focusing on R&D milestones and expected market launch. It is not a formal periodic report (like 10-K or IR), an earnings release (ER), or a specific shareholder document (like DEF 14A or DVA). Since it is a general corporate announcement regarding business development and sustainability efforts ('Sustainability' is listed as a keyword), and it doesn't fit neatly into the other specific categories (like M&A, Capital Change, or Dividend), the most appropriate classification is the general regulatory/news announcement fallback category, RNS (Regulatory Filings). The document length (9844 chars) is substantial enough that it is the announcement itself, not just a brief notice of publication (which would suggest RPA).
2018-06-20 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly contains a 'Notification of Major Holdings' section. It details changes in voting rights percentages (crossing the 3% threshold) held by KBC Asset Management NV in B.R.A.I.N. Biotechnology Research And Information Network AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2018-06-15 English
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG expects double-digit revenue growth in fiscal year 2017/18 despite weak first half year
Earnings Release Classification · 100% confidence The document explicitly states it is announcing the 'financial results for the first half of fiscal year 2017/18' and provides detailed financial tables comparing the 6 months ended March 31, 2018, with the previous year. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year. The classification code for this is 'IR' (Interim / Quarterly Report). Although it is disseminated via a news service (DGAP), the core content is the report itself, not just an announcement of its publication (which would be RPA/RNS). H1 2018
2018-05-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.